American Association of Individual Investors5d
Is Hims & Hers Health Inc Stock (HIMS) a Good Investment?
The value score is the percentile rank of the average of the percentile ranks of the price-to-sales ratio ... to powerful investment discovery tools and a wealth of investment education to help you ...
Hims & Hers Health Stock Is Rising Monday: What's Going On?
Hims & Hers Health Inc (NYSE:HIMS) shares are trading higher Monday. The company is set to join to the S&P SmallCap 600 this ...
Hims & Hers Health Asserts Demand For Its Compounded Weight Loss Offering To Continue Despite Resolved Supply Shortages
The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...
bovnews1d
The Hims & Hers Health Inc Enigma: What’s Causing the Wild Swings in HIMS Stock?
Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $17.66 which represents a slight increase of $0.53 or 3.09% from the prior close of $17.13. The stock opened at $17.55 and ...
Seeking Alpha5d
Is Hims & Hers rally at risk as GLP-1 shortages ease?
LLY's recent decision to slash prices of the two lowest dosing strengths of tirzepatide sent HIMS shares sharply lower in late August. However, HIMS continues to see prospects in a post-shortage ...
TipRanks on MSN15h
HIMS Stock Rises 208% in a Year and Is Ready to Compete with the Big Guns
As a player in the growing telehealth sector, Hims & Hers Health ($HIMS) has grown significantly, driving its stock up over ...
Nasdaq6d
HIMS Factor-Based Stock Analysis
Below is Validea's guru fundamental report for HIMS & HERS HEALTH INC (HIMS). Of the 22 guru strategies we follow, HIMS rates highest using our P/B Growth Investor model based on the published ...
Nasdaq4d
Massive News for Hims & Hers Stock: The Truth About Today's Move
Stock prices used were end-of-day prices of Oct. 3, 2024. The video was published on Oct. 3, 2024. Before you buy stock in Hims & Hers Health, consider this: The Motley Fool Stock Advisor analyst ...
Fast Company5d
Hims & Hers Health stock tanks after FDA says competitor Eli Lilly’s weight-loss drug shortage is over
Shares of Hims & Hers Health fell almost 10% today following an announcement from the U.S. Food and Drug Administration (FDA) that competitor Eli Lilly’s obesity and diabetes drugs are no longer ...
Eli Lilly obesity drug shortage ends fueling lawsuit against FDA
A group representing makers of compounded drugs sued FDA over its decision to call an end to the shortage of Lilly's (LLY) ...
Investopedia5d
Hims & Hers Health Stock Falls as FDA Drops Eli Lilly Weight-Loss Drugs From Shortage List
Bloomberg / Contributor / Getty Images Hims & Hers Health shares tumbled Thursday after the Food and Drug Administration (FDA) said Eli Lilly's popular weight-loss drugs are no longer on its list ...
Zacks.com on MSN11h
Hims & Hers Health (HIMS) Soars 10.1%: Is Further Upside Left in the Stock?
Hims & Hers Health, Inc. HIMS shares rallied 10.1% in the last trading session to close at $19.44. This move can be attributable to notable volume with a higher number of shares being traded than in a ...